BEST STOCKS TO BUY TODAY: VIR @04/23/2023
| Ticker | VIR, Vir Biotechnology, Inc. | Note |
| Last Price | 25.98 | |
| Buy | 25.98 | Limit Order This is generated by our mechanical trading system. Please read the chart section for more detailed and flexible entry options. |
| Target | 28.58 | Default at 10%, Or Sell when close below ma5(short term)/10(midterm)/20(long term) or when big down day or when formed inverted hammer at a resistance level |
| Stop | 24.26 | |
| Reward/Risk | 1.51 : 1 |
Above is the summary of one of our Best Stocks To buy.
More Technical Status
| ATR | 0.79 | |
| Beta | 0.25 | |
| RSI(14) | 67.58 | |
| SMA20 | 9.81% | Distance to SMA20 |
| SMA50 | 8.17% | Distance to SMA50 |
| Recommendation | 1.90 | Analysts’ mean recommendation (1=Buy 5=Sell) |
Our system generated several buy signals today. VIR is one of them. Let’s take a look at this stock’s chart.
VIR made a nice run for the last few weeks and then made a nice consolidation. Now it is breaking out to the upside again. We soon should see it is heading to $29 level.
More info about ticker VIR
VIR is the stock ticker symbol for Vir Biotechnology Inc., a clinical-stage immunology company that develops and commercializes treatments for infectious diseases. The company’s focus is on developing innovative therapies for viruses such as hepatitis B virus, influenza virus, and human immunodeficiency virus (HIV).
Vir Biotechnology is headquartered in San Francisco, California, and was founded in 2016. The company has partnerships with a number of pharmaceutical companies, including GlaxoSmithKline, Alnylam Pharmaceuticals, and Biogen.